Anti-LewisY Chimeric Antigen Receptor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-LewisY Chimeric Antigen Receptor, covering 2012-12-04 to 2012-12-04. Get the full timeline:
Most recent: Clinical Trial Update: Safety Study of Anti LewisY Chimeric Antigen Receptor in Myeloma, Acute Myeloid Leukemia or Myelodysplastic Syndrome [Phase 1]